Corvus Pharmaceuticals, Inc. (CRVS)
17.89
-0.37
(-2.03%)
USD |
NASDAQ |
Mar 02, 16:00
17.67
-0.22
(-1.23%)
After-Hours: 04:33
Corvus Pharmaceuticals Research and Development Expense (TTM) : 29.75M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Plus Therapeutics, Inc. | 7.624M |
| Geron Corp. | 73.72M |
| Jaguar Health, Inc. | 15.19M |
| Krystal Biotech, Inc. | 55.08M |